BioAegis Therapeutics Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 9
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $7M
Latest Deal Amount
  • Investors
  • 1

BioAegis Therapeutics General Information

Description

Operator of a clinical-stage drug development company intended to facilitate the treatment of inflammation and infectious diseases. The company specializes in the research and development of drugs to restore plasma gelsolin, a key component of innate immunity provides an immunotherapeutic approach to fight with pathogens, enabling hospitals to begin treatment more quickly and result in a higher likelihood of successful treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Commercialization Center for Innovative Technology
  • 675 US Highway One
  • North Brunswick, NJ 08902
  • United States
+1 (973) 000-0000

BioAegis Therapeutics Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioAegis Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 07-Oct-2020 $7M 000.00 Completed Clinical Trials - General
6. Debt - PPP 28-Apr-2020 000.00 Completed Clinical Trials - General
5. Later Stage VC (Series B) 01-Aug-2018 00.00 000.00 000.00 Completed Clinical Trials - General
4. Grant 09-Jul-2016 000 000.00 Completed Clinical Trials - General
3. Angel (individual) 11-Mar-2016 00.00 000.00 0000 Completed Startup
2. Angel (individual) 01-Jan-2015 $8.04M $11M 0000 Completed Startup
1. Angel (individual) 08-Feb-2013 $3M $3M Completed Startup
To view BioAegis Therapeutics’s complete valuation and funding history, request access »

BioAegis Therapeutics Executive Team (15)

Name Title Board Seat Contact Info
Steven Cordovano Co-Founder and Vice President of Corporate Development and Communications
Po-Shun Lee Founding Scientist & Scientific Advisor
B. Taylor Thompson MD Clinical Advisory Board Member
John Kellum MD Clinical Advisory Board Member
Steven Opal MD Clinical Advisory Board Member
You’re viewing 5 of 15 executive team members. Get the full list »

BioAegis Therapeutics Board Members (5)

Name Representing Role Since
John Stossel BioAegis Therapeutics Board Member 000 0000
Mark DiNubile MD BioAegis Therapeutics Chief Medical Officer and Board Member 000 0000
Susan Levinson Ph.D Self Co-Founder, Chief Executive Officer and Board Member 000 0000
Valerie Ceva Self Co-Founder, Chief Operating Officer and Board Member 000 0000
To view BioAegis Therapeutics’s complete board members history, request access »

BioAegis Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioAegis Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institute Of Allergy and Infectious Diseases Government 000 0000 000000 0
To view BioAegis Therapeutics’s complete investors history, request access »